SPS
ABOS icon

Susquehanna Portfolio Strategies’s Acumen Pharmaceuticals ABOS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,903
Closed -$54.3K – 19
2024
Q3 		$54.3K Hold
21,903
– – ﹤0.01% 339
2024
Q2 		$53K Hold
21,903
– – ﹤0.01% 494
2024
Q1 		$88.7K Hold
21,903
– – ﹤0.01% 763
2023
Q4 		$84.1K Buy
+21,903
New +$65K ﹤0.01% 980

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Susquehanna Portfolio Strategies's ABOS Position: Q4 2024 in Review

Susquehanna Portfolio Strategies sold out of Acumen Pharmaceuticals (ABOS) in Q4 2024, closing a stake of 21,903 shares — an estimated $54.3K sold.

Susquehanna Portfolio Strategies first reported a position in ABOS in Q4 2023 and held it in 4 quarters. The position peaked at $88.7K in Q1 2024. 80 funds tracked by Wall St. Rank hold ABOS as of Q4 2024.

  • Susquehanna Portfolio Strategies reported no remaining Acumen Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 21,903 Acumen Pharmaceuticals shares in Q4 2024, an estimated $54.3K.
  • Susquehanna Portfolio Strategies first reported a position in Acumen Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Susquehanna Portfolio Strategies's Acumen Pharmaceuticals position peaked at $88.7K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q4 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.